Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities

Neuropsychologia

Volumn 51, Issue 11, 2013, Pages 2202-2209

  Nebes, Robert D ^a   Snitz, Beth E ^a   Cohen, Ann D ^a   Aizenstein, Howard J ^a   Saxton, Judith A ^a   Halligan, Edythe M ^a   Mathis, Chester A ^a   Price, Julie C ^a   Kamboh, M Ilyas ^b   Weissfeld, Lisa A ^b   Klunk, William E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Amyloid; Cognition; Normal aging; White matter hyperintensities

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B;

ADULT; AGED; AGING; ARTICLE; BRAIN FUNCTION; BRAIN SCINTISCANNING; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RATING SCALE; WHITE MATTER LESION; WORKING MEMORY;

AMYLOID; COGNITION; NORMAL AGING; WHITE MATTER HYPERINTENSITIES;

AGED; AGED, 80 AND OVER; AGING; AMYLOID BETA-PEPTIDES; BRAIN; BRAIN MAPPING; COGNITION; FEMALE; HUMANS; MALE; NERVE FIBERS, MYELINATED; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS;

EID: 84884300327     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2013.07.017     Document Type: Article

References (62)

1. Aizenstein H.J., Nebes R.D., Saxton J.A., Price J.C., Mathis C.A., Tsopelas N.D., et al. Frequent amyloid deposition without clinically significant cognitive impairment among the elderly. Archives of Neurology 2008, 65:1509-1517.
2. Albinet C.T., Boucard G., Bouquet C.A., Audiffren A. Processing speed and executive functions in cognitive aging: How to disentangle their mutual relationship?. Brain and Cognition 2012, 79:1-11.
3. Ardila A. Normal aging increases cognitive heterogeneity: Analysis of dispersion in WAIS-III scores across age. Archives of Clinical Neuropsychology 2007, 22:1003-1011.
4. Bäckman L., Jones S., Berger A.K., Laukka E.J., Small B.J. Cognitive impairment in preclinical Alzheimer's disease: A meta-analysis. Neuropsychology 2005, 19:520-531.
5. Bielak A.A.M., Hultsch D.F., Strauss E., MacDonald S.W.S., Hunter M.A. Intraindividual variability is related to cognitive change in older adults. Psychology and Aging 2010, 25:575-586.
6. Bracco L., Piccini C., Moretti M., Mascalchi M., Sforza A., Nacmias B., et al. Alzheimer's disease: Role of size and location of white matter changes in determining cognitive deficits. Dementia and Geriatric Cognitive Disorders 2005, 20:358-366.
7. Brickman A.M., Honig L.S., Scarmeas N., Tatarina O., Sanders L., Albert M.S., et al. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Archives of Neurology 2008, 65:1202-1208.
8. Burgess P.W., Shallice T. Response suppression, initiation and strategy use following frontal lobe lesions. Neuropsychologia 1996, 34:263-272.
9. Cohen A.D., Bi W., Weissfeld L.A., Aizenstein H.J., McDade E., Mountz J.M., et al. Classification of amyloid-positivity in controls: Comparison of visual read and quantitative approaches. NeuroImage 2013, 71:207-215.
10. Cohen A.D., Price J.C., Weissfeld L.A., James J., Rosario B.L., Wenzhu B., et al. Basal cerebral metabolism may modulate the cognitive effects of Aβ in mild cognitive impairment: An example of brain reserve. Journal of Neuroscience 2009, 29:14770-14778.
11. De Groot M., Verhaaren F.J., de Boer R., Klein S., Hofman A., Van der Lugt A., et al. Changes in normal-appearing white matter precede development of white matter lesions. Stroke 2013, 44:1037-1042.
12. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. (1994). Arlington, VA: American Psychiatric Association.
13. Dobbs A.R., Rule B.G. Adult age differences in working memory. Psychology and Aging 1989, 4:500-503.
14. Drachman D.A. Aging of the brain, entropy and Alzheimer disease. Neurology 2006, 67:1340-1352.
15. Driscoll I., Resnick S.M., Troncoso J.C., An Y., O'Brien R., Zonderman A.B. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Annals of Neurology 2006, 60:688-695.
16. Elias M.F., Sullivan L.M., D'Agostino R.B., Elias P.K., Beiser A., Au R., et al. Framingham stroke risk profile and lowered cognitive performance. Stroke 2004, 35:404-409.
17. 42 correlates with brain atrophy in cognitively normal elderly. Annals of Neurology 2009, 65:176-183.
18. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
19. Grimmer T., Henriksen G., Wester H.J., Forstl H., Klunk W.E., Mathis C.A., et al. Clinical severity of Alzheimer's disease is associated with PiB uptake in PET. Neurobiology of Aging 2009, 30:1902-1909.
20. Grimmer, T., Faust, M., Auer, F., Alexopoulos, P., Förstl, H., et al. White matter hyperintensities predict amyloid increase in Alzheimer's disease. Neurobiology of Aging, 33, 2766-2773.
21. Gunning-Dixon F.M., Raz N. The cognitive correlates of white matter abnormalities in normal aging: A quantitative review. Neuropsychology 2000, 14:224-232.
22. Hasher L., Tonev S.T., Lustig C., Zacks R.T. Inhibitory control, environmental support and self-initiated processing in aging. Perspectives on human memory and cognitive aging 2001, 286-297. Psychology Press, New York. M. Naveh-Benjamin, M. Moscovitch, H.L. Roediger (Eds.).
23. Holtzer R., Goldin Y., Zimmerman M., Katz M., Buschke H., Lipton R.B. Robust norms for selected neuropsychological tests in older adults. Archives of Clinical Neuropsychology 2008, 23:531-541.
24. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurology 2010, 9:119-128.
25. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 2008, 131:665-680.
26. Kantarci K., Lowe V., Przybelski S.A., Weigand S.D., Senjem M.L., Ivnik R.J., et al. APOE modifies the association between Aβ load and cognition in cognitively normal older adults. Neurology 2012, 78:232-240.
27. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holdt D.P., et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Annals of Neurology 2004, 55:306-319.
28. Knopman D.S., Penman A.D., Catellier D.J., Coker L.H., Shibata D.K., Sharrett A.R., et al. Vascular risk factors and longitudinal changes on brain MRI. Neurology 2011, 76:1879-1885.
29. Kuo H.K., Sorond F., Iloputaife I., Gagnon M., Milberg W., Lipsitz L.A. Effect of blood pressure on cognitive functions in elderly persons. Journal of Gerontology: Medical Sciences 2004, 59A:1191-1194.
30. Lipsey M.W., Wilson D.B. Practical meta-analysis 2001, Sage Publications, Thousand Oaks, CA.
31. Longstreth W.T., Manolio T.A., Arnold A., Burke G.L., Bryan N., Jungreis C.A., et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. Stroke 1996, 27:1274-1282.
32. Meltzer C.C., Kinahan P.E., Greer P.J., Nichols E., Comtat.C., Cantwell M.N., et al. Comparative evaluation of MR-based partial-volume correction schemes for PET. Journal of Nuclear Medicine 1999, 40:2053-2065.
33. Morris J.C., Roe C.M., Xiong C., Fagan A.M., Goate A.M., Holtzman D.M., et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Annals of Neurology 2010, 67:122-131.
34. Oh H., Madison C., Haight T.J., Markley C., Jagust W.J. Effects of age and β-amyloid on cognitive changes in normal elderly people. Neurobiology of Aging 2012, 33:2746-2755.
35. Oh H., Morminoi E.C., Madison C., Hayenga A., Smiljic A., Jagust W.J. β-Amyloid affects frontal and posterior brain networks in normal aging. NeuroImage 2011, 54:1887-1895.
36. Park D.C., Hedden T. Working memory and aging. Perspectives on human memory and cognitive aging 2001, 148-160. Psychology Press, New York. M. Naveh-Benjamin, M. Moscovitch, H.L. Roediger (Eds.).
37. Perrotin A., Mormino E.C., Madison C.M., Hayenga A.O., Jagust W.J. Subjective cognition and amyloid deposition imaging. Archives of Neurology 2012, 69:223-229.
38. Petersen R.C. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 2004, 256:183-194.
39. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment. Archives of Neurology 1999, 56:303-308.
40. Pike K.E., Ellis K.A., Villemagne V.L., Good M., Chételat G., Ames D., et al. Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study. Neuropsychologia 2011, 49:2384-2390.
41. Pike K.E., Savage G., Villemagne V.L., Ng S., Moss S.A., Maruff P., et al. β-amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer's disease. Brain 2007, 130:2837-2844.
42. Price J.C., Klunk W.E., Lopresti B.J., Lu X., Hoge J.A., Ziolko S.K., et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound -B. Journal of Cerebral Blood Flow & Metabolism 2005, 25:1528-1547.
43. Psychological Corporation WAIS-III-WMS-III technical manual 1997, Author, San Antonio.
44. Rabbitt P. Aging and cognition. Steven's handbook of experimental psychology" 2002, 793-860. John Wiley & Sons, New York. 3rd ed. H. Pashler (Ed.).
45. Rabbitt P., Scott M., Lunn M., Thacker N., Lowe C., Pendelton N., et al. White matter lesions account for all age-related declines in speed but not in intelligence. Neuropsychology 2007, 21:363-370.
46. Raz N., Lindenberger U., Rodrigue K.M., Kennedy K.M., Head D., Williamson A., et al. Regional brain changes in aging healthy adults: General trends, individual differences and modifiers. Cerebral Cortex 2005, 15:1676-1689.
47. Rodrigue K.M., Kennedy K.M., Devous M.D., Rieck J.R., Hebrank A.C., Diaz-Arrastia R., et al. β-Amyloid burden in healthy aging. Neurology 2012, 78:387-395.
48. Rodrigue K.M., Kennedy K.M., Park D.C. Beta-amyloid deposition and the aging brain. Neuropsychological Review 2009, 19:436-450.
49. Rodrigue K.M., Rieck J.R., Kennedy K.M., Devous M.D., Diaz-Arrastia R., Park D.C. Risk factors for β-amyloid deposition in healthy aging. JAMA Neurology 2013, 70:600-606.
50. Rowe C.C., Ellis K.A., Rimajova M., Bourgeat P., Pike K.E., Jones G., et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiology of Aging 2010, 31:1275-1283.
51. Salthouse T.A. Aging and measures of processing speed. Biological Psychology 2000, 54:35-54.
52. Söderlund H., Nilsson L.G., Berger K., Breteler M.M., Dufouil C., Fuhrer R., et al. Cerebral changes on MRI and cognitive function. Neurobiology of Aging 2006, 27:16-23.
53. Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A.M., et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's and Dementia 2011, 7:280-292.
54. Spieler D.H., Balota D.A., Faust M.E. Stroop performance in healthy younger and older adults and in individuals with dementia of the Alzheimer's type. Journal of Experimental Psychology: Human Perception & Performance 1996, 22:461-479.
55. Storandt M., Mintun M.A., Head D., Morris J.C. Cognitive decline and brain volume loss as signatures of cerebral amyloid-β peptide deposition identified with Pittsburgh Compound B. Archives of Neurology 2009, 66:1476-1481.
56. Taki Y., Kinomura S., Sato K., Goto R., Wu K., Kawashima R., et al. Correlation between gray/white matter volume and cognition in healthy elderly people. Brain and Cognition 2011, 75:170-176.
57. Waldstein S.R., Katzel L.I. Hypertension and cognitive function. Neuropsychology of cardiovascular disease 2000, 15-36. Lawrence Erlbaum Associates, Mahwah, NJ. S.R. Waldstein, M.F. Elias (Eds.).
58. Wechsler D. Wechsler test of adult reading 2001, Psychological Corporation, New York, NY.
59. Windblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., et al. Mild cognitive impairment-beyond controversies, towards a consensus. Journal of Internal Medicine 2004, 256:240-246.
60. Wolk D.A., Price J.C., Saxton J.A., Snitz B.E., James J.A., Lopez O.L., et al. Amyloid imaging in mild cognitive impairment subtypes. Annals of Neurology 2009, 65:557-568.
61. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M.B., et al. Development and validation of a geriatric depression screening scale. Journal of Psychiatric Research 1983, 17:37-49.
62. Yue N., Arnold A., Longstreth W., Elster A.D., Jungreis C.A., O'Leary D.H., et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: Data from the Cardiovascular Health Study. Radiology 1997, 202:33-39.